Detalles de la búsqueda
1.
Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.
Mol Metab
; 55: 101392, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781035
2.
Whole-brain activation signatures of weight-lowering drugs.
Mol Metab
; 47: 101171, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529728
3.
An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy.
Neuroinformatics
; 19(3): 433-446, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063286
4.
A genetic map of the mouse dorsal vagal complex and its role in obesity.
Nat Metab
; 3(4): 530-545, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767443
5.
The dorsomedial hypothalamus and nucleus of the solitary tract as key regulators in a rat model of chronic obesity.
Brain Res
; 1727: 146538, 2020 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31705862
6.
SORLA Expression in Synaptic Plexiform Layers of Mouse Retina.
Mol Neurobiol
; 57(7): 3106-3117, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472518
7.
Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss.
Sci Rep
; 9(1): 16161, 2019 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695063
8.
Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.
Dis Model Mech
; 12(11)2019 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31704726
9.
Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease.
Front Neuroanat
; 11: 109, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29276478
10.
Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Brain Res
; 1665: 22-35, 2017 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411086
11.
The endogenous preproglucagon system is not essential for gut growth homeostasis in mice.
Mol Metab
; 6(7): 681-692, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28702324
12.
Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.
Diabetes
; 66(7): 2007-2018, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408435
13.
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass.
Mol Metab
; 5(4): 296-304, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27069869
14.
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on ß-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
PLoS One
; 11(7): e0158205, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27421117
15.
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Brain Res
; 1646: 354-365, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27233809
16.
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Brain Res
; 1634: 158-170, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26746341
17.
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
J Alzheimers Dis
; 46(4): 877-88, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25869785
Resultados
1 -
17
de 17
1
Próxima >
>>